2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid | CAS:114873-37-9

We serve 2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid CAS:114873-37-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid

Chemical Name:2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
CAS.NO:114873-37-9
Synonyms:2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid
1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid
1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic) acid
4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane
Molecular Formula:C14H26N4O6
Molecular Weight:346.37900
 
Specification:
Appearance:Beige Coloured Solid
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is an intermediate for the synthesis of Des(2-Hydroxypropyl) Gadoteridol (D290340), which is a contrast imaging agent metabolite from Gadoteridol (G125900), used as an MRI contrast chelating agent.



Contact us for information like 2-[4,7-bis(carboxymethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid Use and application,1,4,7,10-Tetraazacyclododecane-1,4,7-triaceticacid technical grade,usp/ep/jp grade.


Related News: “With early evidence of clinical activity for our off-the-shelf, iPSC-derived NK cell programs, we are excited to lead in bringing next-generation CAR T-cell therapies to patients and plan to submit an IND for FT819 in the first half of 2020.”Bis-TBDMS-trans-calcipotriol manufacturer Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.9-bromo-10-(2-biphenyl)anthracene supplier Common signs of infection include respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. In more severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death.1,2,3,9-Tetrahydro-4(H)-Carbazol-4-One vendor ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.